Vir Biotechnology Inc (VIR)
10.25
-0.14
(-1.35%)
USD |
NASDAQ |
May 31, 16:00
10.27
+0.02
(+0.20%)
After-Hours: 20:00
Vir Biotechnology Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.68M |
| September 30, 2023 | 0.277M |
| June 30, 2023 | 3.179M |
| March 31, 2023 | 2.344M |
| December 31, 2022 | 2.011M |
| September 30, 2022 | 1.985M |
| June 30, 2022 | 3.08M |
| March 31, 2022 | 27.68M |
| December 31, 2021 | 5.67M |
| September 30, 2021 | 3.629M |
| Date | Value |
|---|---|
| June 30, 2021 | 3.529M |
| March 31, 2021 | 87.50M |
| December 31, 2020 | -0.259M |
| September 30, 2020 | 324.31M |
| June 30, 2020 | 205.34M |
| March 31, 2020 | 0.085M |
| December 31, 2019 | 130.10M |
| September 30, 2019 | 1.732M |
| June 30, 2019 | 0.003M |
| March 31, 2019 | 317.41M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.259M
Minimum
Dec 2020
324.31M
Maximum
Sep 2020
42.31M
Average
3.08M
Median
Jun 2022
Cash from Financing (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | -357.50M |
| NovaBay Pharmaceuticals Inc | -0.597M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 5.025M |
| Theriva Biologics Inc | 0.00 |
Cash from Financing (Quarterly) Related Metrics
| Free Cash Flow | -800.36M |
| Free Cash Flow Per Share (Quarterly) | -0.8132 |
| Free Cash Flow to Equity (Quarterly) | -109.46M |
| Free Cash Flow to Firm (Quarterly) | -109.46M |
| Free Cash Flow Yield | -58.03% |